A Long-term Study of NPC-12G Gel in Neurofibromatosis Type I

Status Terminated

Clinical Trial Summary

The purpose of this tria is to evaluate the safety and efficacy of long-term treatment with NPC-12G gel to patients with neurofibromatosis type I.

Clinical Trial Description

A Phase 3, open-label, uncontrolled, multicenter study to evaluate the safety and efficacy of long-term treatment with NPC-12G gel for patients with neurofibromatosis type I. Patients who meet all entry criteria for this trial apply NPC-12G gel twice a day for 52 weeks or more. Approximately 100 eligible patients will be enrolled. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04461886
Study type	Interventional
Source	Nobelpharma
Contact
Status	Terminated
Phase	Phase 3
Start date	July 8, 2020
Completion date	December 7, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00754780` - Clinical Trial of Pirfenidone in Adult Patients With Neurofibromatosis 1	Phase 2
Completed	`NCT00589784` - Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma	Phase 2
Recruiting	`NCT04463316` - GROWing Up With Rare GENEtic Syndromes
Completed	`NCT01673009` - Phase II Study of Gleevec/Imatinib Mesylate (STI-571, NCS 716051) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas	Phase 2
Recruiting	`NCT00598351` - Natural History Study of Patients With Neurofibromatosis Type 2
Completed	`NCT02298270` - Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype	N/A
Terminated	`NCT01402817` - Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas	Phase 2
Completed	`NCT02101736` - Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults	Phase 2
Completed	`NCT01633008` - Acceptance and Commitment Therapy for Adolescents and Young Adults With Neurofibromatosis and Chronic Pain	Early Phase 1
Completed	`NCT01275586` - Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas	Early Phase 1
Completed	`NCT02435628` - Relationship Between Psychosocial Factors, Health Literacy, Quality of Life and Satisfaction With Medical Visits in Adults With NF	N/A
Active, not recruiting	`NCT01140360` - Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas	Phase 1/Phase 2
Completed	`NCT02211768` - Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1	Phase 1
Completed	`NCT00508235` - Quality of Friendships in Children With Neurofibromatosis	N/A
Completed	`NCT01639950` - Validating Pain Scales in Children and Young Adults